Sveriges mest populära poddar
The AI in Business Podcast
NäringslivTeknologi

Qrativ's Murali Aravamudan on "What's Possible" for AI in Drug Discovery

27 min•14 oktober 2017

In this episode, we talk to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm reference. Murali and I discuss the surge of medical information and data in the medical industry, the role of artificial intelligence in developing drugs for treatments to various diseases, and the future of AI in drug discovery.

For more in-depth interviews on the business applications of artificial intelligence, find us online at:

www.TechEmergence.com

Fler avsnitt av The AI in Business Podcast

Visa alla avsnitt av The AI in Business Podcast
Connecting Forecasting and Warehouse Decisions at Scale - with Jerod Hamilton of Tyson Foods
•24 min
Decentralized Trials That Scale Globally Without Compliance Risks - with Emma Vitalini of Amgen
•30 min
Solving the Expertise Gap with AI in Manufacturing - with Antoine Bisson of Poka
•30 min
How Digital K‑1 Data Changes Tax Workflow Maturity - with Ken Powell and Neal Schneider
•30 min
Closing the Customer Service Gap: How AI Is Redefining Scale, Speed, and Satisfaction - with Philipp Heltewig of NiCE
•40 min
Creating a Single Source of Truth for Enterprise Legal Work - with Christo Siebrits of AbbVie
•21 min
What Global Tariff Uncertainty Means for Supply Chain Leaders - with Edmund Zagorin of Arkestro and Michael Shin of Trinity Rail Industries
•46 min
Managing Third-Party Risk at Scale Without Drowning in Surveys - with Carey Smith
•14 min
Why Enterprise AI Fails Without a Context Engine - with Eran Yahav of Tabnine
•31 min
From AI Experiments to Enterprise Value Driving Real Business ROI - with Dan Diasio of EY
•39 min

The AI in Business Podcast med Daniel Faggella finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.